Search research articles
Contact Us
Filters
Showing results (181-190 of 354) with videos related to
Page
of 36
Sort By:
Neuroimmune Pharmacology and Therapeutics
|
February 26, 2024
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's disease
Milica Markovic, Pravin Yeapuri, Krista L Namminga, et al.
Neurobiology of Disease
|
January 25, 2020
Immunotherapy for Parkinson's disease
Aaron D Schwab, Mackenzie J Thurston, Jatin Machhi, et al.
Antiviral Research
|
June 1, 2015
Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice
Pavan Puligujja, Mariluz Araínga, Prasanta Dash, et al.
Pharmaceutics
|
February 24, 2024
Polymer Delivery Systems for Long-Acting Antiretroviral Drugs
Mohammad Ullah Nayan, Sudipta Panja, Ashrafi Sultana, et al.
Nanotoxicology
|
December 24, 2010
Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage
Rafael F Bressani, Ari S Nowacek, Sangya Singh, et al.
Clinical and Translational Medicine
|
July 8, 2022
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
Mai M Abdelmoaty, Jatin Machhi, Pravin Yeapuri, et al.
Glia
|
September 3, 2003
Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia
Radhika Suryadevara, Spring Holter, Kathleen Borgmann, et al.
Plos One
|
July 14, 2009
CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction
Tomomi Kiyota, Masaru Yamamoto, Huangui Xiong, et al.
Nanomedicine (London, England)
|
March 21, 2014
Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues
Dhirender Singh, JoEllyn M McMillan, Xin-Ming Liu, et al.
Neuroimmune Pharmacology and Therapeutics
|
May 2, 2025
The 29th Scientific Conference of the Society on NeuroImmune Pharmacology in Omaha, NE, June 8-12, 2025
Allison M Andrews, Linda Chang, Rosemarie Booze, et al.
Page
of 36
Search research articles
Search
Showing results (181-190 of 354) with videos related to
Sort By:
Page
of 36
Neuroimmune Pharmacology and Therapeutics
|
February 26, 2024
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's disease
Milica Markovic, Pravin Yeapuri, Krista L Namminga, et al.
Neurobiology of Disease
|
January 25, 2020
Immunotherapy for Parkinson's disease
Aaron D Schwab, Mackenzie J Thurston, Jatin Machhi, et al.
Antiviral Research
|
June 1, 2015
Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice
Pavan Puligujja, Mariluz Araínga, Prasanta Dash, et al.
Pharmaceutics
|
February 24, 2024
Polymer Delivery Systems for Long-Acting Antiretroviral Drugs
Mohammad Ullah Nayan, Sudipta Panja, Ashrafi Sultana, et al.
Nanotoxicology
|
December 24, 2010
Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage
Rafael F Bressani, Ari S Nowacek, Sangya Singh, et al.
Clinical and Translational Medicine
|
July 8, 2022
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
Mai M Abdelmoaty, Jatin Machhi, Pravin Yeapuri, et al.
Glia
|
September 3, 2003
Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia
Radhika Suryadevara, Spring Holter, Kathleen Borgmann, et al.
Plos One
|
July 14, 2009
CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction
Tomomi Kiyota, Masaru Yamamoto, Huangui Xiong, et al.
Nanomedicine (London, England)
|
March 21, 2014
Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues
Dhirender Singh, JoEllyn M McMillan, Xin-Ming Liu, et al.
Neuroimmune Pharmacology and Therapeutics
|
May 2, 2025
The 29th Scientific Conference of the Society on NeuroImmune Pharmacology in Omaha, NE, June 8-12, 2025
Allison M Andrews, Linda Chang, Rosemarie Booze, et al.
Page
of 36